Delivery Order SPE2DB25D9303-SPE2DB25FPUSJ
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $8,622.72 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract, which carries no set-aside designation, is set for ultimate completion by September 4, 2025, and represents a delivery order issued under DMS Pharmaceutical Group's substantial Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,311.35 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $17,245.40 by the Defense Logistics Agency (DLA) on August 1, 2025. The contract, which carries no set-aside designation, calls for the delivery of 120 units of Xtandi 40 mg capsules, an oncology medication used in the treatment of prostate cancer. The delivery order is scheduled for completion by August 4, 2025, with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,311.35 by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of September 17, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency (DLA) on June 5, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract, which carries no set-aside designation, is scheduled for ultimate completion by June 6, 2025, with performance taking place at the vendor's Park Ridge facility. This delivery order was...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for the supply of Xtandi 40 mg capsules (120-count units) with a ceiling value of $17,245.40. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. This award carries no set-aside designation, demonstrating the company's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $17,245.40 by the Defense Logistics Agency on August 13, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The award carries no set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. This award is issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract ceiling value is $38,376.87, with an ultimate completion date of September 11, 2025. This delivery order carries no set-aside designation and represents a direct fulfillment order under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,565.70 for Xtandi 40mg capsules (120 count) by the Defense Logistics Agency's Medical Supply Chain on September 13, 2025. This firm fixed-price delivery order carries no set-aside designation and is being performed at the awardee's Park Ridge location. The award represents a single delivery order under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 14, 2025, for the supply of Xtandi 40 mg tablets (120-count units) with a ceiling value of $4,169.59. This firm fixed-price delivery order carries an ultimate completion date of July 15, 2025, and represents part of the company's ongoing pharmaceutical supply relationship with the Defense Logistics Agency (DLA) Medical Supply Chain division....
- SPE2DB25D9303Indefinite Delivery Contract
- SPE2DB25D9303-SPE2DB25FPUSJDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,311.35 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The delivery order carries an ultimate completion date of August 1, 2025, and was issued without set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The SPE2DB program serves as a critical supply chain mechanism for the DLA to distribute prescription medications, biologics, and medical consumables to military health facilities across the globe. Xtandi, an oncology treatment used in prostate cancer therapy, aligns with DMS Pharmaceutical Group's established portfolio of specialized pharmaceutical products delivered to federal healthcare systems. As the prime contractor on this delivery order, DMS Pharmaceutical Group will perform all work at its facility in Park Ridge, Illinois, leveraging its position as a substantial supplier within the federal pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/31/25 |